Concord Biotech Ltd (CONB)

Currency in INR
1,873.90
-5.30(-0.28%)
Delayed Data·

CONB Financial Summary

Key Ratios

P/E Ratio52.82
Price/Book10.83
Debt / Equity0.16%
Return on Equity22.26%
Dividend Yield0.00%
EBITDA5.06B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 35.52%
Dividend Yield
-
Industry Median 0.74%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 29, 2025
EPS / Forecast
13.40 / --
Revenue / Forecast
4.30B / --
EPS Revisions
Last 90 days

FAQ

What were Concord Biotech Ltd's earnings for the latest quarter?

The Concord Biotech Ltd EPS (TTM) is 35.52. Concord Biotech Ltd reported sales of 4,298.84, net income of 1,403.87, and EPS of 13.40 for the latest quarter.

What was Concord Biotech Ltd's net income for the latest quarter?

Concord Biotech Ltd's net income for the latest quarter was 1,403.87.

How did Concord Biotech Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 2,442.20 in the previous quarter to 4,298.84 in the latest quarter, and net income moved from 759.21 to 1,403.87 compared to the previous quarter.

What is Concord Biotech Ltd's net profit margin on a TTM basis?

Concord Biotech Ltd's trailing twelve months (TTM) net profit margin is 30.97%.

How does Concord Biotech Ltd's debt to equity ratio compare to industry standards?

Concord Biotech Ltd's total debt-to-equity ratio is 0.16%.

What is Concord Biotech Ltd's return on investment on a TTM basis?

Concord Biotech Ltd's trailing twelve months (TTM) return on investment (ROI) is 22.26%.

What were Concord Biotech Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Concord Biotech Ltd reported total assets of 20,342.52 million and total liabilities of 1,840.63 million.

How has Concord Biotech Ltd's total revenue grown this year?

Concord Biotech Ltd's total revenue was 2,442.20 in the previous quarter and 4,298.84 in the latest quarter.

What is Concord Biotech Ltd's gross margin on a TTM basis?

Concord Biotech Ltd's trailing twelve months (TTM) gross margin is 65.19%.

What was Concord Biotech Ltd's revenue per share for the latest quarter?

Concord Biotech Ltd's revenue per share for the latest quarter was 296.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.